Therapeutic effects of β-caryophyllene on proliferative disorders and inflammation of the gerbil prostate

Prostate. 2021 Sep;81(12):812-824. doi: 10.1002/pros.24177. Epub 2021 Jun 14.

Abstract

Background: The prostate is susceptible to changes in androgen levels, which can play an important role in the development of Benign Prostatic Hyperplasia (BPH). Natural compounds have beneficial properties for organisms and can be an important therapeutic strategy in the treatment of diseases. β-Caryophyllene (BCP) is a phytocannabinoid present in several medicinal and food plants species and has shown beneficial effects in different organs. However, little is known about its effects on the prostate. The present study seeks to evaluate the effects of exposure to BCP on the morphophysiology of the ventral prostate of adult gerbils supplemented with testosterone.

Methods: Animals were distributed into four groups (n = 8/group): Intact control (C); β-Caryophyllene (BCP): β-Caryophyllene (50 mg/kg/day); Testosterone (T): animals received subcutaneous injections of Testosterone Cypionate (3 mg/Kg), on alternate days, for one month and were euthanized 30 days supplementation ended; Testosterone and β-Caryophyllene (TBCP): animals were exposed to testosterone cypionate (3 mg/Kg) to induce hyperplastic alterations followed by daily BCP (50 mg/kg). Morphological, biometric, immunohistochemical, and serological analyses were performed.

Results: Proliferative disorders and inflammatory foci were present in the ventral prostate of all experimental groups. An increase in the multiplicity of benign intraepithelial neoplasm and subepithelial inflammatory foci was observed in T group. The incidence of intraluminal inflammatory foci and microinvasive carcinoma was verified only in the T group. Cellular rearrangement and tissue remodeling occurred in the prostate of groups exposed to phytocannabinoids. A reduction was observed in the frequency of PHH3 and Cox2 markers in the prostatic epithelium of TBCP in comparison with T. A decrease in F4/80 and CD163 positive macrophages were also observed in the prostatic stroma of the TBCP group in comparison with T. The results suggest that BCP had favorable effects on BPH, reducing the proliferation and frequency of some inflammatory cells.

Conclusion: BCP impacts the tissue remodeling process in the premalignant prostate environment and that the use of this phytocannabinoid can have a promising effect in the handling of BPH.

Keywords: BPH; inflammatory cells; macrophages; phytocannabinoid; tissue remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Cell Proliferation / drug effects*
  • Cell Proliferation / physiology
  • Gerbillinae
  • Injections, Subcutaneous
  • Male
  • Polycyclic Sesquiterpenes / administration & dosage*
  • Prostate / drug effects*
  • Prostate / pathology
  • Prostatic Hyperplasia / chemically induced*
  • Prostatic Hyperplasia / drug therapy*
  • Prostatic Hyperplasia / pathology
  • Testosterone / administration & dosage
  • Testosterone / analogs & derivatives
  • Testosterone / toxicity
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Polycyclic Sesquiterpenes
  • Testosterone
  • caryophyllene
  • testosterone 17 beta-cypionate